Stock image Oral Antidiabetic page 2
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.3MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.72MB, 3024 × 4032 jpg
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Structural Chemical, Dark Blue Background. Vector Illustration
Vector, 0.31MB, 6124 × 4082 eps
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Molecular Model. 3D Rendering. Illustration
Image, 6.03MB, 9000 × 4460 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Structural Chemical Formula, Dark Blue Background. Vector Illustration
Vector, 0.31MB, 6847 × 3651 eps
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.25MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.39MB, 3024 × 4032 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.3MB, 4032 × 3024 jpg
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Skeletal Chemical Formula. Paper Packaging For Drugs. Vector Illustration
Vector, 0.31MB, 6547 × 3819 eps
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.37MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.24MB, 3024 × 4032 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Structural Chemical Formula, Molecule Model. Vector Illustration
Vector, 0.43MB, 5590 × 4472 eps
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.24MB, 3024 × 4032 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.42MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.12MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.2MB, 4032 × 3024 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.32MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.33MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.28MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.23MB, 4032 × 3024 jpg
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.32MB, 3024 × 4032 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.24MB, 3024 × 4032 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.28MB, 3024 × 4032 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Molecular Model. 3D Rendering. Illustration
Image, 1.77MB, 5070 × 2420 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Skeletal Chemical Formula. Paper Packaging For Drugs. Vector Illustration
Vector, 0.34MB, 6755 × 3701 eps
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.37MB, 3024 × 4032 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.27MB, 4032 × 3024 jpg
Prague, Czech Republic-June 27 2024: Metformin TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Diabetes
Image, 2.35MB, 3024 × 4032 jpg
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Molecular Model. 3D Rendering. Illustration
Image, 2.45MB, 5071 × 3383 jpg
Empagliflozin Molecule. It Is Antidiabetic Medication, SGLT2 Inhibitor. Sheet Of Paper In A Cage. Vector Illustration
Vector, 0.45MB, 5916 × 4226 eps
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.33MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.21MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.59MB, 3024 × 4032 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Molecular Model. 3D Rendering. Illustration
Image, 6.35MB, 9700 × 4600 jpg
Glibenclamide, Glyburide Molecule. Sulfonylurea Used In The Treatment Of Non Insulin Dependent Diabetes Mellitus. Molecule Model. Sheet Of Paper In A Cage. Vector Illustration
Vector, 0.47MB, 5916 × 4226 eps
Prague, Czech Republic - July 9 2024: SITAGLIPTIN METFORMIN TEVA Box Of Tablets With SITAGLIPTIN And METFORMIN Active Substances By TEVA, Used For Treatment Of Type 2 Diabetes.
Image, 2.24MB, 4032 × 3024 jpg
Prague, Czech Republic - June 28 2024: METFORMIN TEVA Box Of Medication With Metformin Hydrochloride Active Substance By Teva Pharmaceuticals, Used For Treatment Of Type 2 Diabetes, Insulin Resistance.
Image, 2.56MB, 3024 × 4032 jpg
Previous << Page 2 >> Next